Anne E. Cress

6.8k total citations · 1 hit paper
147 papers, 5.4k citations indexed

About

Anne E. Cress is a scholar working on Molecular Biology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne E. Cress has authored 147 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 55 papers in Immunology and Allergy and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne E. Cress's work include Cell Adhesion Molecules Research (55 papers), Prostate Cancer Treatment and Research (32 papers) and Protease and Inhibitor Mechanisms (20 papers). Anne E. Cress is often cited by papers focused on Cell Adhesion Molecules Research (55 papers), Prostate Cancer Treatment and Research (32 papers) and Protease and Inhibitor Mechanisms (20 papers). Anne E. Cress collaborates with scholars based in United States, Cyprus and Germany. Anne E. Cress's co-authors include Raymond B. Nagle, William S. Dalton, Lori Hazlehurst, Ray B. Nagle, Jason S. Damiano, Аlexander А. Shtil, Eugene W. Gerner, Isaac Rabinovitz, Bruce L. Dalkin and William S. Dalton and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Anne E. Cress

145 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

1999 718 citations Anne E. Cress, Lori Hazlehurst et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne E. Cress United States	41	2.8k	1.8k	1.4k	931	924	147	5.4k
Giulia Taraboletti Italy	47	4.0k 1.4×	2.1k 1.2×	1.1k 0.7×	2.2k 2.4×	506 0.5×	112	7.1k
Lubor Borsig Switzerland	43	3.3k 1.2×	2.1k 1.2×	1.1k 0.7×	942 1.0×	580 0.6×	99	7.1k
Shafaat A. Rabbani Canada	50	3.9k 1.4×	2.5k 1.4×	628 0.4×	2.2k 2.3×	1.1k 1.2×	136	6.7k
L. A. Liotta United States	21	3.0k 1.1×	1.7k 1.0×	842 0.6×	1.8k 2.0×	483 0.5×	39	4.9k
Catherine Butterfield United States	22	3.8k 1.4×	1.4k 0.8×	611 0.4×	1.8k 1.9×	731 0.8×	33	6.5k
Sara M. Weis United States	31	4.3k 1.5×	1.6k 0.9×	1.3k 0.9×	1.6k 1.7×	498 0.5×	53	7.3k
Inés Martín-Padura Italy	34	3.1k 1.1×	906 0.5×	1.5k 1.0×	672 0.7×	276 0.3×	50	5.9k
Antonino Passaniti United States	39	3.6k 1.3×	1.1k 0.6×	521 0.4×	1.5k 1.6×	549 0.6×	85	5.6k
József Tı́már Hungary	50	4.0k 1.4×	3.2k 1.8×	965 0.7×	1.9k 2.0×	1.4k 1.5×	328	8.4k
Jasti S. Rao United States	54	4.4k 1.5×	2.4k 1.3×	1.2k 0.8×	3.8k 4.1×	500 0.5×	169	8.3k

Countries citing papers authored by Anne E. Cress

Since Specialization

Citations

This map shows the geographic impact of Anne E. Cress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Cress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Cress more than expected).

Fields of papers citing papers by Anne E. Cress

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E. Cress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Cress. The network helps show where Anne E. Cress may publish in the future.

Co-authorship network of co-authors of Anne E. Cress

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. Cress. A scholar is included among the top collaborators of Anne E. Cress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E. Cress. Anne E. Cress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liou, Hope, Lauren E. Ball, Jennifer R. Bethard, et al.. (2023). PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology. 222(6). 10 indexed citations

Gard, Jaime M.C., Charles W. Wolgemuth, Beatrice S. Knudsen, et al.. (2023). Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo. Biophysical Journal. 122(21). 4194–4206. 2 indexed citations

Nagle, Ray B., et al.. (2022). Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers. Frontiers in Cell and Developmental Biology. 10. 837585–837585. 5 indexed citations

Chauhan, Shailender S., Rachel K. Toth, Alva G. Sainz, et al.. (2021). Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors. Oncogene. 40(32). 5142–5152. 22 indexed citations

Johnson, Michael D. L., Kenneth J. Addison, Aprile L. Pilon, et al.. (2020). CC16 Binding to α4β1 Integrin Protects Against Mycoplasma Pneumoniae Infection. American Journal of Respiratory and Critical Care Medicine. 203(11). 1410–1418. 23 indexed citations

Gard, Jaime M.C., Mengdie Wang, James P. Hinton, et al.. (2019). Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell–Cell Biophysical Properties in Prostate Cancer. Cancer Research. 79(18). 4703–4714. 9 indexed citations

Wang, Mengdie, James P. Hinton, Jaime M.C. Gard, et al.. (2019). Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell–cell and cell–extracellular matrix interactions. Molecular Biology of the Cell. 30(7). 838–850. 6 indexed citations

Das, Lipsa, Jaime M.C. Gard, Rytis Prekeris, et al.. (2018). Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Molecular Cancer Research. 16(8). 1319–1331. 15 indexed citations

Huang, Fangjin, Jamie M. Sperger, Joshua M. Lang, et al.. (2018). Regulation of inside-out β1-integrin activation by CDCP1. Oncogene. 37(21). 2817–2836. 13 indexed citations

10.

Chen, Weiguo, Yulia Epshtein, Randal O. Dull, et al.. (2015). Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress. Scientific Reports. 5(1). 16529–16529. 28 indexed citations

11.

Samulitis, Betty K., Anne E. Cress, Hitendra Patel, et al.. (2014). Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biology & Therapy. 16(1). 43–51. 54 indexed citations

12.

Sroka, Isis C., et al.. (2014). Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines. Biochemical and Biophysical Research Communications. 454(2). 335–340. 12 indexed citations

13.

Sroka, Isis C., et al.. (2011). Macrophage-Dependent Cleavage of the Laminin Receptor α6β1 in Prostate Cancer. Molecular Cancer Research. 9(10). 1319–1328. 21 indexed citations

14.

Emmons, Michael F., Rajesh R. Nair, Rachid Baz, et al.. (2011). Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype. Molecular Cancer Therapeutics. 10(12). 2257–2266. 24 indexed citations

15.

Nair, Rajesh R., Michael F. Emmons, Anne E. Cress, et al.. (2009). HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells. Molecular Cancer Therapeutics. 8(8). 2441–2451. 33 indexed citations

16.

Sroka, Isis C., Gerald D. Pond, Raymond B. Nagle, et al.. (2009). Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. PubMed. 2(1). 59–66. 7 indexed citations

17.

Clerck, Yves A. De, Bernard E. Weissman, Dihua Yu, et al.. (2006). Tumor progression and metastasis from genetic to microenvironmental determinants. Cancer Biology & Therapy. 5(12). 1588–1599. 1 indexed citations

18.

Schmelz, Monika, Anne E. Cress, Katherine Scott, et al.. (2002). Different phenotypes in human prostate cancer. Neoplasia. 4(3). 243–254. 3 indexed citations

19.

Cress, Anne E., et al.. (1989). Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. Biochemical Pharmacology. 38(23). 4283–4290. 20 indexed citations

20.

Herman, Terence S., Anne E. Cress, & Eugene W. Gerner. (1979). Collateral sensitivity to methotrexate in cells resistant to adriamycin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(6 Pt 1). 1937–42. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact